European Archives - Page 237 of 1107 - European Medical Journal

Invasive Neuromodulation: Present and Future

NEUROMODULATION was the overarching theme of the European Academy of Neurology (EAN) Congress 2024, held from 29th June–2nd…

Idebenone Treatment for Leber Hereditary Optic Neuropathy

Leber hereditary optic neuropathy (LHON) is a mitochondrial disease resulting in bilateral central vision loss, primarily caused by one…

Nipocalimab and gMG: Top Line Results from the Phase III Vivacity-MG3 Study

Nipocalimab, a high-affinity, fully human, aglycosylated, effectorless, monoclonal antibody, has been developed as an add-on treatment…

EAN 2024 Abstract Highlights

The following highlights showcase late breaking research presented at the 10th European Academy of Neurology (EAN) Congress. Topics ranged…

Diagnosing Synucleinopathies

Parkinson’s disease (PD) is the second-most common neurodegenerative disease after Alzheimer’s disease (AD), with an estimated…

Patterns of Laryngeal Changes on Clinical Application of Mechanical Insufflation-Exsufflation

Individuals with neuromuscular diseases (NMD), where deterioration in bulbar function coexists with respiratory muscle weakness, are at…

A Rare Case of Cervical Intramedullary Spinal Cord Abscess

The occurrence of intramedullary spinal cord abscesses (ISCA) is rare, a phenomenon attributable to a confluence of physiological and…

Bromocriptine in the Management of Central Hyperthermia

Fever is a common medical issue encountered in neurorehabilitation units. The most common cause of fever is infection; the common…

AZ, GSK, Novartis, BMS and Sanofi lead Q2 2024 sales growth

The pharma industry shows strong growth into the second quarter of 2024, with companies reporting substantial YoY profit increases in Q2.

Ustekinumab: A Promising Early Treatment for Type 1 Diabetes

Researchers at Cardiff University have identified that Ustekinumab may effectively manage the early stages of Type 1 diabetes in children and adolescents.